Qualitroth Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 1 Year 9 Months
- Last Filing with ROC 31 Mar 2024
About Qualitroth Pharmaceuticals
The Company is engaged in the Paper Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dhanshri Mali, Priyanka Kadam, Supriya Purkar, and One other member serve as directors at the Company.
- CIN/LLPIN
U21001MH2023PTC399653
- Company No.
399653
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2023
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nashik, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Qualitroth Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhanshri Mali  | Director | 26-Mar-2023 | Current |
| Priyanka Kadam | Director | 26-Apr-2023 | Current |
| Supriya Purkar | Director | 26-Mar-2023 | Current |
| Urmila Wagh | Director | 26-Mar-2023 | Current |
Financial Performance of Qualitroth Pharmaceuticals.
Enhance accessibility to Qualitroth Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Qualitroth Pharmaceuticals?
Unlock access to Qualitroth Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Mahilavishwa Farmer Producer Company LimitedActive 11 months 2 days
Priyanka Kadam is a mutual person
- Virdhaara Farmer Producer Company LimitedInactive For E-Filing 9 months 9 days
Priyanka Kadam is a mutual person
- Samrajya Agro Farmer Producer Company LimitedActive 8 months 26 days
Priyanka Kadam is a mutual person
- Ramrajya Krushi Udyojak Producer Company LimitedActive 3 months 6 days
Priyanka Kadam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Qualitroth Pharmaceuticals?
Unlock and access historical data on people associated with Qualitroth Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Qualitroth Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qualitroth Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
